Skip to content
healthcare.dev
Get a free key

ALYFTREK

NDC 51167-135, vanzacaftor, tezacaftor, and deutivacaftor, tablet, film coated, from Vertex Pharmaceuticals Incorporated.

Product NDC
51167-135
Status
Listed
Labeler
Vertex Pharmaceuticals Incorporated
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA218730
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51167-135 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • VANZACAFTOR4 mg/1
  • TEZACAFTOR20 mg/1
  • DEUTIVACAFTOR50 mg/1

Pharmacologic classes

Breast Cancer Resistance Protein Inhibitors [MoA]; Chloride Channel Activation Potentiators [MoA]; Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]; Cytochrome P450 2C9 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]

Package NDCNDC-11Package
51167-135-01511670135014 BLISTER PACK in 1 CARTON (51167-135-01) / 21 TABLET, FILM COATED in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7e635909-c6fd-4f0d-ae77-cdff03653a20

Use it

Look up 51167-135 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51167-135 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51167-135. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.